The company develops machine learning for protein engineering via its machine learning-driven evolution engine (EVA platform) and will combine its expertise with Ablynx's existing therapeutic Nanobody protein technology, it said. The optimized candidates will then be advanced by Ablynx into further validation studies.

Financial terms of the partnership were not disclosed.

Elektrofi, Takeda partner to advance plasma protein therapeutics
Biotechnology firm Elektrofi and Takeda Pharmaceuticals have partnered to advance high-concentration, low-viscosity protein therapeutics.

BrickBio advances conjugation platform for therapeutic development
BrickBio has demonstrated the power of its conjugation platform process for the commercial development of biologics in-house and with pharmaceutical partners.